|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/205 | (2013.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61K 9/2027 | (2013.01) | ||
| A61K 9/2846 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 31/216 | (2013.01) | ||
| A61K 47/14 | (2017.01) | ||
| A61K 31/65 | (2013.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 31/7012 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 31/7036 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/2054 | (2013.01) | ||
| A61K 47/50 | (2017.01) | ||
| A61K 38/09 | (2013.01) | ||
| A61K 9/2013 | (2013.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 31/16 | (2018.01) | ||
| A61P 3/06 | (2018.01) |
| (11) | Number of the document | 3244878 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16708750.1 |
| Date of filing the European patent application | 2016-01-12 | |
| (97) | Date of publication of the European application | 2017-11-22 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/012970 |
| Date | 2016-01-12 |
| (87) | Number | WO 2016/115082 |
| Date | 2016-07-21 |
| (30) | Number | Date | Country code |
| 201562102263 P | 2015-01-12 | US |
| (72) |
VRETTOS, John , US
DAGGS, Thomas , US
SHIELDS, Paul , US
CLAUDIO, Raymundo , US
|
| (73) |
Enteris BioPharma, Inc. ,
83 Fulton Street, Boonton, NJ 07005,
US
|
| (54) | SOLID ORAL DOSAGE FORMS |
| SOLID ORAL DOSAGE FORMS |